INTRODUCTION
Placenta accreta is a condition characterized by abnormal adherence of either in whole or a part of placenta to the uterine wall. The true incidence of placenta accrete is difficult to quantify accurately but it is estimated to be between 1/7000 to 1/2000 deliveries in developed countries. Over the last 50 years, the incidence of placenta accreta is estimated to have increased ten-fold. 1 
CASE REPORT
A 30 years aged Mrs XYZ, G2P1A0 with 32 weeks of pregnancy with previous caesarean was admitted as a case of placenta previa with complaints of bleeding per vaginum of 1 pad partially soiled and fever since 3 days. Her LMP was not known. Her 1st delivery was a full term caesarean 4 years back.
On admission, her pulse was 140/min and BP was 120/70. Pallor was ++, Urine albumin was trace. On per abdomen examination, scar of caesarean present, uterus was 32 weeks, relaxed, cephalic floating, FHS 156/min, No scar tenderness. On speculum examination: slight bleeding was present and os was closed.
On investigation, hemoglobin was 8.0 gm%. Serum widal was positive. Urine showed plenty of pus cells. Liver and renal functions as well as S. TSH were normal. ECG showed sinus tachycardia. Ultrasonography showed single live intrauterine fetus of 32 weeks, cephalic with placenta previa. Placenta was central, completely covering the internal os.
She was given 3 red cell concentrate and antibiotics were started. She was kept on expectant line of management with regular monitoring for bleeding, vitals and fetal growth.
At 37 weeks, elective caesarean was done. Lower segment was well formed with prominent dilated vessels over lower segment and traversing towards the bladder base. So incision was placed slightly higher, above the previous scar along an avascular plane. On placing incision over lower segment, placenta came into the view, which was attached along the previous scar. Baby was approached only after separating the placenta attached over the upper margin of incision. Membrane was ruptured. Baby was delivered by vertex, male live 3.2 kg.
Attempt was made to remove the placenta attached to lower part of incision. There was no plane of cleavage between the decidua and placenta. So, placenta was removed piece meal with some part being left behind. There was torrential haemorrhage. Patient developed severe hypotension and was started on injectable dopamine and dobutamine. Box sutures were taken to control the bleeding. There was slight oozing so the uterus was packed with roller gauze, with one end of gauze being pushed in vagina, and then the incision was closed with vicryl no. 1. Care was taken so that the gauze was not stitched while closing the incision. Haemostasis was secured. Patient maintained her vitals with dopamine and dobutamine. Patient was given 4 units PCV, 1 FFP and higher antibiotics. Injection oxytocin was continued post operatively for 12 hours. Inj. dopamine and dobutamine were tapered postoperatively and omitted within 12 hours. After 18 hours, the pack was removed vaginally after starting injection oxytocin 20 units, which was continued for 4 hours. There was no active bleeding at that time. The Post-operative period was uneventful.
Injection methotrexate was given on 8th day following the regime of 1, 3, 5, 7 with injection folinic acid on alternate days. Lochia remained healthy with soakage of 1 pad per day during this time. Patient was discharged on 16th day with oral antibiotics, which were continued for 7 days. At that time, uterus was subinvoluted to 14-16 wks size & ultrasonography showed presence of retained products. She was advised to follow up weekly and/or if heavy bleeding per vaginum. She stopped bleeding from 20th day.
At 6 wks, she came with complain of bleeding since 3 days with 2 pads soaked per day. Uterus was subinvoluted to 14-16wks size with os closed. USG showed retained placenta with hypervascularity. Her haemoglobin was 9.9 gm/dL, total count, platelet count, liver and renal function tests were normal. She was readmitted and D&E was done in the presence of anaesthetists. Patient had been counseled that hysterectomy might have to be done if heavy bleeding occurs. About 100 gms of placental bits were removed on D&E. 1 unit of blood was given. On discharge uterus was 10 weeks without any retained products.
DISCUSSION
The mainstay of traditional management in cases of placenta accreta is abdominal hysterectomy and its prompt undertaking has been shown to reduce maternal mortality. However, it is often delayed, as it is perceived as a difficult procedure at caesarean delivery and the complication rate may be significant. Also, it ends fertility and may cause serious psychological consequences.
Leaving the placenta in situ is possibly the most important aspect of conservative management. If there is a high index of suspicion of accreta then, unless the placenta can be removed with the minimum effort and a cleavage plane can be found easily, no further attempts to remove it should be made. 2, 6 In this manner, the fused area between the placenta and the myometrium is not disrupted and it is expected that bleeding will be minimal. If this is the case during normal delivery, the umbilical cord can be cut short and the placenta left undisturbed in situ. And if it occurs at the time of caesarean section, uterus closed in routine fashion. It has implications for infection and therefore the woman is generally covered with broad spectrum intravenous antibiotics for a variable time period. 6 It is possible that the use of methotrexate hastens the resolution of the placenta. A number of reports have described of passing of placental tissues after 5 and 13 days following intensive intravenous methotrexate 7, 8, 9, 10 and 18 days following high-dose oral methotrexate.
11 Though women not treated with methotrexate do not appear to be unduly disadvantaged. 12 Outcome generally does not vary whether methotrexate is used or not.
There is no consensus as to whether the placenta should be removed in the postpartum period or left to (presumably) resorb or to be passed spontaneously. One option to reduce bleeding is to ascertain by doppler ultrasound when the vascularity of the placenta has ceased and then consider removing it. 3 This does not guarantee success. 1 Leaving the placenta in situ with planned interval removal, if nothing else, may facilitate a more planned approach to potentially high-risk surgery. Though complications of leaving the placenta in situ have also been reported. 1 It is possible to excise the placental site. 13 If the area of accreta is focal and the majority of the placenta has been removed, then a wedge resection of the area can be performed. 1 Bilateral uterine artery embolisation, argon beam coagulation of the placental bed and Pelvic artery ligation (anterior division of internal iliac or uterine artery) have been mentioned with varying success. [14] [15] [16] If the placenta has been left in situ, the woman requires follow-up to ensure the resolution of placental tissue. This is done with a combination of clinical assessment, ultrasound examination and serum ß-hCG assay. 6, 7, 11 Significant reduction of ß-hCG to low levels does not, however, mean that uterine hemorrhage will not occur and it has been omitted with no apparent deleterious effects in a number of cases. 6, 7, 11 Ultrasonography is useful in assessing placental involution 2, 7, 11 and has been combined with colour Doppler imaging to determine placental vascularity. 2, 3 
